SAN DIEGO, Feb. 1, 2013 /PRNewswire/ -- TandemDiabetes Care, Inc. (“Tandem”) announced today that it has acquired ownership from Smiths Medical ASD, Inc. of over 23 U.S. patents and patent applications relating to the treatment of diabetes. As part of this transaction, Tandem has also obtained a license to 28 other U.S. patents and patent applications owned by Smiths Medical. This license affords Tandem exclusive access to technologies useful for future product development in the field of ambulatory infusion pumps and related software and accessories for the treatment of diabetes. These patents and patent applications complement Tandem’s growing portfolio of intellectual property related to the company’s novel technologies.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a privately held company dedicated to advancing the management of diabetes through novel technologies. The Company offers a comprehensive, user-centric and integrated approach to product design, development, and customer care. Tandem Diabetes Care is based in San Diego, Calif.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslim.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetesCorp.
Tandem Diabetes Care is a registered trademark of Tandem Diabetes Care, Inc.
SOURCE Tandem Diabetes Care, Inc.
